Comments
Loading...

Outlook Therapeutics

OTLKNASDAQ
Logo brought to you by Benzinga Data
$6.00
0.071.18%
At Close: -
$6.15
0.152.50%
After Hours: 4:00 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$53.00
Lowest Price Target1
$1.00
Consensus Price Target1
$21.95

Outlook Therapeutics (NASDAQ:OTLK) Stock, Analyst Ratings, Price Targets, Forecasts

Outlook Therapeutics Inc has a consensus price target of $21.95 based on the ratings of 9 analysts. The high is $53 issued by Chardan Capital on August 16, 2024. The low is $1 issued by Cantor Fitzgerald on August 30, 2023. The 3 most-recent analyst ratings were released by Ascendiant Capital, Chardan Capital, and HC Wainwright & Co. on September 3, 2024, August 16, 2024, and August 15, 2024, respectively. With an average price target of $38.67 between Ascendiant Capital, Chardan Capital, and HC Wainwright & Co., there's an implied 528.73% upside for Outlook Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Mar
0
0
0
0
May
0
0
0
0
Aug
0
0
0
0
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Ascendiant Capital
Chardan Capital
HC Wainwright & Co.
BTIG
Guggenheim

1calculated from analyst ratings

Analyst Ratings for Outlook Therapeutics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Outlook Therapeutics (OTLK) stock?

A

The latest price target for Outlook Therapeutics (NASDAQ:OTLK) was reported by Ascendiant Capital on September 3, 2024. The analyst firm set a price target for $33.00 expecting OTLK to rise to within 12 months (a possible 436.59% upside). 12 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Outlook Therapeutics (OTLK)?

A

The latest analyst rating for Outlook Therapeutics (NASDAQ:OTLK) was provided by Ascendiant Capital, and Outlook Therapeutics maintained their buy rating.

Q

When was the last upgrade for Outlook Therapeutics (OTLK)?

A

The last upgrade for Outlook Therapeutics Inc happened on March 27, 2024 when BTIG raised their price target to $50. BTIG previously had a neutral for Outlook Therapeutics Inc.

Q

When was the last downgrade for Outlook Therapeutics (OTLK)?

A

The last downgrade for Outlook Therapeutics Inc happened on August 31, 2023 when Chardan Capital changed their price target from N/A to N/A for Outlook Therapeutics Inc.

Q

When is the next analyst rating going to be posted or updated for Outlook Therapeutics (OTLK)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Outlook Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Outlook Therapeutics was filed on September 3, 2024 so you should expect the next rating to be made available sometime around September 3, 2025.

Q

Is the Analyst Rating Outlook Therapeutics (OTLK) correct?

A

While ratings are subjective and will change, the latest Outlook Therapeutics (OTLK) rating was a maintained with a price target of $35.00 to $33.00. The current price Outlook Therapeutics (OTLK) is trading at is $6.15, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch